BVFL vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BVFL presents a compelling value opportunity, trading at a significant discount to both its Graham Number ($26.88) and Intrinsic Value ($42.18). The company exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and explosive year-over-year earnings growth of 218.60%. While technical trends and insider sentiment are currently bearish, the fundamental valuation—highlighted by a Price-to-Book ratio of 0.90—suggests the stock is undervalued relative to its assets and growth trajectory.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BVFL vs JPM: Head-to-Head Comparison
This page compares BV Financial, Inc. (BVFL) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.